161 related articles for article (PubMed ID: 16198612)
21. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
22. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
23. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
24. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
25. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
Sobolewski P
Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin: new treatment for temporomandibular disorders.
Freund B; Schwartz M; Symington JM
Br J Oral Maxillofac Surg; 2000 Oct; 38(5):466-71. PubMed ID: 11010775
[TBL] [Abstract][Full Text] [Related]
27. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
28. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Arch Phys Med Rehabil; 2006 Dec; 87(12):1551-8. PubMed ID: 17141633
[TBL] [Abstract][Full Text] [Related]
29. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
[TBL] [Abstract][Full Text] [Related]
30. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.
Giannantoni A; Costantini E; Di Stasi SM; Tascini MC; Bini V; Porena M
Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
Voller B; Földy D; Hefter H; Auff E; Schnider P
Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
[TBL] [Abstract][Full Text] [Related]
32. [Botulinum toxin: a new dimension for spasticity].
Reichel G
MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
[TBL] [Abstract][Full Text] [Related]
33. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke.
Farina S; Migliorini C; Gandolfi M; Bertolasi L; Casarotto M; Manganotti P; Fiaschi A; Smania N
Funct Neurol; 2008; 23(2):87-91. PubMed ID: 18671909
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
37. Effect of botulinum toxin type A on gait of children who are idiopathic toe-walkers.
Brunt D; Woo R; Kim HD; Ko MS; Senesac C; Li S
J Surg Orthop Adv; 2004; 13(3):149-55. PubMed ID: 15559690
[TBL] [Abstract][Full Text] [Related]
38. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
[TBL] [Abstract][Full Text] [Related]
39. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
[TBL] [Abstract][Full Text] [Related]
40. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]